MCAM and peripheral arterial disease: Researchers interested in PAD-associated inflammation, endothelial proliferation, or VEGF signaling, as just a few examples, might include additional targeted molecular imaging sessions designed to track the expression levels of the receptor for advanced glycosylation end-products (RAGE) 54 CD105 55, CD146 56, or VEGFR 57, respectively.